Lakhmir S. Chawla
2017
In 2017, Lakhmir S. Chawla earned a total compensation of $2.2M as Chief Medical Officer at La Jolla Pharmaceutical, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,000 |
|---|---|
| Option Awards | $1,455,057 |
| Salary | $431,000 |
| Other | $73,497 |
| Total | $2,175,554 |
Chawla received $1.5M in option awards, accounting for 67% of the total pay in 2017.
Chawla also received $216K in non-equity incentive plan, $431K in salary and $73.5K in other compensation.
Rankings
In 2017, Lakhmir S. Chawla's compensation ranked 5,113th out of 14,666 executives tracked by ExecPay. In other words, Chawla earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,113 out of 14,666 | 65th |
Division Manufacturing | 1,817 out of 5,770 | 69th |
Major group Chemicals And Allied Products | 538 out of 2,074 | 74th |
Industry group Drugs | 414 out of 1,730 | 76th |
Industry Biological Products, Except Diagnostic Substances | 74 out of 316 | 77th |
Source: SEC filing on August 22, 2018.
Chawla's colleagues
We found four more compensation records of executives who worked with Lakhmir S. Chawla at La Jolla Pharmaceutical in 2017.